PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 18243359-3 2008 The expression of AChE-R was blocked with a systemically administered central acting antisense oligonucleotide for AChE-R (EN101). Oligonucleotides 95-110 acetylcholinesterase Mus musculus 18-24 25793201-0 2015 Corrigendum to "Presymptomatic treatment with acetylcholinesterase antisense oligonucleotides prolongs survival in ALS (G93A-SOD1) mice". Oligonucleotides 77-93 acetylcholinesterase Mus musculus 46-66 24455732-0 2013 Presymptomatic treatment with acetylcholinesterase antisense oligonucleotides prolongs survival in ALS (G93A-SOD1) mice. Oligonucleotides 61-77 acetylcholinesterase Mus musculus 30-50 24455732-2 2013 AChE enzyme inhibitors can upregulate AChE transcription which in certain contexts can have deleterious (noncatalytic) effects, making them theoretically harmful in ALS, whilst AChE antisense-oligonucleotides (mEN101), which downregulate AChE may be beneficial. Oligonucleotides 192-208 acetylcholinesterase Mus musculus 0-4 24455732-2 2013 AChE enzyme inhibitors can upregulate AChE transcription which in certain contexts can have deleterious (noncatalytic) effects, making them theoretically harmful in ALS, whilst AChE antisense-oligonucleotides (mEN101), which downregulate AChE may be beneficial. Oligonucleotides 192-208 acetylcholinesterase Mus musculus 38-42 24455732-2 2013 AChE enzyme inhibitors can upregulate AChE transcription which in certain contexts can have deleterious (noncatalytic) effects, making them theoretically harmful in ALS, whilst AChE antisense-oligonucleotides (mEN101), which downregulate AChE may be beneficial. Oligonucleotides 192-208 acetylcholinesterase Mus musculus 38-42 24455732-2 2013 AChE enzyme inhibitors can upregulate AChE transcription which in certain contexts can have deleterious (noncatalytic) effects, making them theoretically harmful in ALS, whilst AChE antisense-oligonucleotides (mEN101), which downregulate AChE may be beneficial. Oligonucleotides 192-208 acetylcholinesterase Mus musculus 38-42 18243359-3 2008 The expression of AChE-R was blocked with a systemically administered central acting antisense oligonucleotide for AChE-R (EN101). Oligonucleotides 95-110 acetylcholinesterase Mus musculus 115-121 14581933-4 2004 Selective downregulation of AChE-R mRNA and protein by antisense oligonucleotides abolished the stress-associated increase in AChE-R, the elevation of contextual fear and LTP in the hippocampal CA1 region. Oligonucleotides 65-81 acetylcholinesterase Mus musculus 28-32 15852394-2 2005 We report that peripheral administration of the acetylcholinesterase inhibitors tacrine, rivastigmine, neostigmine, or EN101 (an antisense oligonucleotide directed at acetylcholinesterase messenger RNA) to mice significantly attenuated the production of interleukin-1beta in the hippocampus and blood, concomitantly with the reduction in acetylcholinesterase activity. Oligonucleotides 139-154 acetylcholinesterase Mus musculus 48-68 15852394-2 2005 We report that peripheral administration of the acetylcholinesterase inhibitors tacrine, rivastigmine, neostigmine, or EN101 (an antisense oligonucleotide directed at acetylcholinesterase messenger RNA) to mice significantly attenuated the production of interleukin-1beta in the hippocampus and blood, concomitantly with the reduction in acetylcholinesterase activity. Oligonucleotides 139-154 acetylcholinesterase Mus musculus 167-187 15852394-2 2005 We report that peripheral administration of the acetylcholinesterase inhibitors tacrine, rivastigmine, neostigmine, or EN101 (an antisense oligonucleotide directed at acetylcholinesterase messenger RNA) to mice significantly attenuated the production of interleukin-1beta in the hippocampus and blood, concomitantly with the reduction in acetylcholinesterase activity. Oligonucleotides 139-154 acetylcholinesterase Mus musculus 167-187 14581933-4 2004 Selective downregulation of AChE-R mRNA and protein by antisense oligonucleotides abolished the stress-associated increase in AChE-R, the elevation of contextual fear and LTP in the hippocampal CA1 region. Oligonucleotides 65-81 acetylcholinesterase Mus musculus 126-130 10854041-6 2000 2"-O-methyl-protected antisense oligonucleotides targeted to AChE mRNA suppressed feedback upregulation of AChE and ameliorated DFP-induced NMJ proliferation. Oligonucleotides 32-48 acetylcholinesterase Mus musculus 61-65 10854041-6 2000 2"-O-methyl-protected antisense oligonucleotides targeted to AChE mRNA suppressed feedback upregulation of AChE and ameliorated DFP-induced NMJ proliferation. Oligonucleotides 32-48 acetylcholinesterase Mus musculus 107-111